Pharmacology, Toxicology and Pharmaceutical Science
Vaccine Development
100%
Clinical Trial
100%
Neutralizing Antibody
100%
Zika Virus Vaccine
100%
Zika Virus
75%
Flavivirus
50%
Vaccine
50%
DNA
25%
Yellow Fever
25%
Mosquito
25%
Monoclonal Antibody
25%
Immunoassay
25%
Clinical Study
25%
Japanese Encephalitis Vaccine
25%
Tick Borne Encephalitis
25%
Inactivated Virus Vaccine
25%
Immunology and Microbiology
Development
100%
Neutralizing Antibody
100%
Zika Virus Vaccine
100%
Vaccine Efficacy
75%
Zika Virus
75%
Flavivirus
50%
Health
25%
Mosquito
25%
Tissues
25%
Monoclonal Antibody
25%
Aptitude
25%
Yellow Fever
25%
Tick-Borne Encephalitis
25%
Immunoassay
25%
Japanese Encephalitis Vaccine
25%
Inactivated Virus Vaccine
25%
INIS
evaluation
100%
vaccines
100%
antibodies
50%
clinical trials
37%
zika virus
37%
encephalitis
25%
public health
12%
dna
12%
mosquitoes
12%
tissues
12%
ticks
12%
monoclonal antibodies
12%
africa
12%
fever
12%
viruses
12%
brazil
12%
prophylaxis
12%
uganda
12%